Yes Bedger, selling now (below the entitlement price) was/is defo a bit premature.
Understand revenue capture has been poor and SP is not reflecting positivity. However, noting current momentum from partnerships and a company only listed around the on-set of COVID (with a recent push for commercialization) - I really see it oversold.
Next 4 quarters are crucial that being said. Management would really need to pull their socks up.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(4.00%) |
Mkt cap ! $2.485M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $13.46K | 1.105M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 897614 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 116308 | 1 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| OSX (ASX) Chart |